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1. Introduction   
Cartilage is a type of connective tissue found throughout the body. The three major types of 
cartilage are distinguished by their physical properties, which reflect their relative contents 
of the extracellular matrices: proteoglycan, elastin fiber and collagen. Hyaline cartilage, 
which makes smooth joint surfaces at the ends of bone, is hard and translucent. It is rich in 
type II collagen and hydrophilic proteoglycans, and highly resistance to pressure and shear 
forces. Elastic cartilage, found in the epiglottis and the Eustachian tube, contains large 
amounts of elastin fibers throughout the matrix, making it stiff but elastic. Fibrocartilage is 
often found in areas subjected to frequent compressive stress, such as intervertebral discs 
and menisci. It contains more collagen (especially type I collagen) and less proteoglycan 
than hyaline cartilage, enabling fibrocartilage to resist pressure effectively.  
Among the many orthopedic conditions, osteoarthritis is one of the most common 
degenerative joint disorders. Osteoarthritis progresses slowly but steadily to the stage where 
articular cartilage has to be entirely regenerated or replaced with an artificial joint. 
Traditional treatments for osteoarthritis deal with the symptoms. While current treatments 
might offer transient relief of pain, no regenerative therapy has yet been established. 
Instead, the best available treatment for patients with advanced osteoarthritic disease is 
surgery to provide an artificial joint. Joint articular cartilage lacks blood vessels and nerves, 
so damaged cartilage is not spontaneously healed by resident, (if they exist), or nearby (e.g. 
synovial) chondroprogenitors. In the current climate, chondroprogenitor transplantation is 
considered a promising therapy for the regeneration of articular cartilage.   
Focal damage to articular cartilage, such as that caused by sports injury, can be repaired by 
regenerative surgery such as the microfracture method, which has been performed for many 
years. Injured cartilage is removed, subchondral bone is exposed and several tiny holes 
(microfractures) are created in the bone to cause bone marrow cells and blood to clot and 
cover the cleared area, thereby promoting healing and tissue repair.  
Osteochondral grafting is also performed, in which full-thickness cylindrical plugs of 
articular cartilage attached to the subchondral bone are directly inserted into matching holes 
drilled in the chondral defect. Recently, cell-based therapies such as autologous chondrocyte 
implantation (ACI) have been developed for use in various clinical settings (Brittberg et al., 
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1994; Gikas et al., 2009; Moriya et al., 2007; Roberts et al., 2009). ACI involves clearing the 
damaged site and covering it with a periosteal patch or a collagen membrane, under which 
expanded articular chondrocytes are placed. ACI therefore requires the sampling of 
chondrocytes from normal area of the patient’s articular cartilage and their expansion in 
culture to obtain enough cells for treatment. The drawback of the procedure is that in vitro 
expansion causes de-differentiation of the cells (i.e. loss of chondrocytic phenotypes). Most 
of the clinical trials of these methods published to date have reported unsatisfactory results. 
The endogenous marrow cells or implanted de-differentiated chondrocytes used for the 
microfracture method and ACI, respectively, have shown limited capacity for proliferation 
and re-differentiation, and tended to produce fibrocartilaginous tissue that fills the cleared, 
damaged sites or the spaces around the plugs, but is poorly integrated into the surrounding 
hyaline cartilage. The osteochondral grafting method suffers from a similar integration 
problem. As a result, the repaired site is often destabilized by tensile and shear forces and 
lost as a result, leading to the need for subsequent surgery (Steinert et al., 2007). 
2. Stem cells for articular cartilage regeneration  
Chondrocytes developed from endogenous marrow cells or from those once 
dedifferentiated in vitro apparently fail to make hyaline cartilage matrix in vivo, even after a 
long-period of time. It is unclear whether the cells of either origin are intrinsically incapable 
of generating hyaline cartilage, or the environment of diseased/damaged sites is not 
conducive to the formation of hyaline cartilage. To date, no attempt to overcome the 
problem has been successful. Furthermore, ACI has the additional drawbacks of 1) requiring 
the isolation of chondrocytes from the patient’s normal cartilage, thereby introducing the 
long-term risk of the procedure itself inducing a degenerative cartilage disorder, and 2) 
requiring an effective method, not yet available, for the expansion/dedifferentiation of 
chondrocytes before transplantation that maintains their redifferentiation capacity. A better 
source of chondrocytes for joint repair and better knowledge of the critical environmental 
cues for the development of hyaline cartilage by chondrocytes are clearly needed (Bianco et 
al., 2008). 
2.1 Adult stem cells 
Mesenchymal stem cells (MSCs), originally isolated from bone marrow (Pittenger et al., 
1999), are defined in vitro based on their tri-lineage (i.e. bone, cartilage and fat) 
differentiation potential and capacity to grow in a clonal fashion (i.e. MSC represents 
colony-forming unit-fibroblast or CFU-F). Similar cells are known to reside in other adult 
tissues such as adipose tissue, skeletal muscle, periosteum, synovial membrane, and the 
dental pulp of deciduous baby teeth (Asakura et al., 2001; De Bari et al., 2001a; De Bari et al., 
2001b; Gronthos et al., 2000; Zuk et al., 2002). Since MSCs are capable of proliferating and 
differentiating into chondrocytes in vitro and in vivo, they were expected to contribute to 
regenerative therapies for cartilage. However, as for other adult stem cells, the major 
drawbacks of MSCs for clinical purposes are 1) MSCs are present at low incidence in adult 
tissues, necessitating in vitro expansion before transplantation, and 2) MSCs have a strong 
proliferative capacity that diminishes over time; however during proliferation their 
chondrogenic potential is not stable. As for chondrocytes, these limitations make it difficult 
to prepare sufficient fully functional MSCs for transplantation. Furthermore, the yield, 
proliferation capacity, and differentiation potential of MSCs decrease with advancing age, 
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limiting the usefulness of clinical application of autologous MSCs in the patient group that 
would most benefit, namely aged adults (Murphy et al., 2002; Tokalov et al., 2007).  
Despite the limitations described, MSCs have been used instead of dedifferentiated 
chondrocytes for ACI. However, to date, the reported results show that the modified 
method is no better than conventional ACI in the longer term. The MSC treatment, in 
combination with growth/differentiation factor-treatment, demonstrates a benefit at 1-2 
months, after which the MSC-derived chondrocytes are lost or have matured into 
hypertrophic chondrocytes that form osteophytes (Steinert et al., 2007). 
2.2 Pluripotent stem cells: embryonic stem cells and induced pluripotent stem cells 
Embryonic stem (ES) cells were first established from the inner cell mass of mouse 
blastocysts (Evans & Kaufman, 1981; Martin, 1981). They are described as ‘pluripotent’ 
because when injected back into blastocysts, ES cells contribute to all somatic tissues formed 
during subsequent embryogenesis. Eighteen years later, ES-like cells from human 
blastocysts were established (Thomson et al., 1998), although their pluripotency has only 
been inferred based on their teratoma forming activity in immunocompromised mice. 
Human ES cells have two advantages over adult stem cells for transplantation therapy. They 
proliferate in culture without the loss of differentiation capacity over a prolonged period, 
allowing the production of a large number of stem cells. Second, they are theoretically 
capable of differentiating into any somatic cell types in culture, given the right growth 
conditions, i.e. those that mimic stages of embryogenesis (reviewed in Gadue et al., 2005; 
Keller, 2005; Nishikawa et al., 2007).  
With the exception of growth plate chondrogenesis, which continues into early adolescence, 
chondrogenesis is largely completed before birth. Robust chondrogenesis during 
embryogenesis is a multi-step process involving development of chondrogenic 
mesenchyme, precartilage condensation of the mesenchyme, the development of 
chondrocytes, and their maturation into different types. The chondrogenic mesenchymal 
cells migrate, proliferate and condense through interaction with the adjacent epithelium. In 
precartilage condensation, cells continue to proliferate and start to differentiate toward 
chondroblasts, while depositing extracellular matrix containing type II, IX, X and XI 
collagens and aggrecan. The chondroblasts then proliferate and differentiate into 
chondrocytes. Finally, growth plate chondrocytes mature into the larger “hypertrophic” 
chondrocytes that are destined for mineralization. These processes are known to be 
regulated by hormones and growth factors, such as transforming growth factor (TGF) β, 
Wnts, fibroblast growth factors (FGFs), bone morphogenetic proteins (BMPs), insulin-like 
growth factors (IGFs), sonic/indian hedgehog (Shh/Ihh), and parathyroid hormone-related 
peptide (PTHrP) (reviewed in Goldring et al., 2006). 
Embryonic chondroprogenitors thus have potential as a promising alternative for cartilage 
cell therapy. Due to the large number of cells required for clinical purposes, embryonic 
tissues are not a practical source of chondroprogenitors. For humans, progeny derived from 
human ES cells seem to be the only source of embryonic cells. Major impediments to the 
clinical use of human ES cell progeny are the risk that contamination of undifferentiated ES 
cells could lead to teratoma formation in patients, and the limited immunological diversity 
of available human ES cell lines. The technical and ethical issues involved in producing 
more such lines have created the need for allogeneic transplantation, which carries the risk 
of immunological complications. 
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There is now a solution to the problem of too few human ES cell lines. In the past couple of 
years, a nuclear reprogramming technology has been established that enables the induction 
of ES cell-like pluripotent stem (PS) cells from mouse and human somatic cells (Park et al., 
2008; Takahashi & Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007). The technology is 
based on viral vector-mediated gene transfer into the target somatic cells in culture. Forced 
expression of pluripotency genes, such as Pou5f1 (Oct3/4), Sox2, Klf4, Nanog and/or Lin28, 
and the myc oncogene alters the pattern of epigenetic modifications that accumulate on 
chromatin, to re-establish the transcriptional profile of ES cells, and gives rise to colonies of 
cells morphologically similar to ES cells. The reprogrammed cells, induced pluripotent stem 
(iPS) cells, display self-renewal and differentiation capacities equivalent to those of ES cells. 
Since somatic cells from individual patients can give rise to iPS cells, this technology has 
opened a practical path toward establishing individualized human PS cells that avoid the 
immunological problems associated with allografting. Use of the technology also avoids the 
controversies surrounding the establishment of human ES cells. However, the current iPS 
technology depends on stable integration of pluripotency gene cDNAs into the chromatin of 
the recipient, a manipulation that could introduce harmful genetic alterations that in the 
long term manifest, for example, as tumors, as observed in cases of gene therapy (Nienhuis 
et al., 2006). In this respect, novel non-integrative methods using a transient-transfection 
protocol (Okita et al., 2008), EBV-based episomal vector (Yu et al., 2009), an adenoviral 
vector (Stadtfeld et al., 2008), a Sendai virus vector (Fusaki et al., 2009), small molecules (Shi 
et al., 2008), or the piggyBac method (Kaji et al., 2009; Woltjen et al., 2009; Yusa et al., 2009) 
have all been reported.  Such methods are likely to lead to the creation in the near future of 
safer, transgene-free human iPS cell lines suitable for clinical applications.  
3. Chondrogenesis from mouse and human PS cells. 
 The ability of ES cells to form cartilage was first seen as cartilage nodule formation in 
teratomas. Chondrogenic differentiation of mouse and human ES cells has been 
demonstrated. Here we summarize methods for the initial differentiation of ES cells and the 
subsequent derivation of chondrocytes.  
3.1 Chondrogenesis in the embryoid body and the outgrowth. 
Embryoid bodies (EBs), the floating cellular aggregates spontaneously generated from PS 
cells in vitro, allow stem cells to differentiate into a number of cell types derived from each 
of the three germ layers (endoderm, mesoderm, and ectoderm) in a process that can 
recapitulate early embryogenesis. As a result, the method of EB formation is widely used for 
directing ES cell differentiation toward chondrocytic lineages.  
For the induction of chondrogenesis, mouse ES cells are differentiated for 5 days in the form 
of EBs in a serum-containing medium (Fig. 1). EBs are then attached to plastic surface to 
allows outgrowth of mesenchymal cells, so-called ‘outgrowth culture’, Fig. 1-1).  When 
outgrowth culture is performed in a chondrogenic medium, some of the mesenchymal cells 
condense to form cartilage nodules (Kramer et al., 2000). Periodic stimulation of 
chondrogenic gene expression and electron-microscopic analysis of the nodules (Kramer et 
al., 2005b) have indicated that the process of in vivo chondrogenesis, from mesenchymal cells 
through chondroprogenitor cells to mature chondrocytes, and finally to hypertrophic 
chondrocytes, can be reproduced in culture. However, the efficiency of cartilage nodule 
formation varies significantly among mouse ES cell lines (Kramer et al., 2005a).  
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Fig. 1. General strategies for differentiating pluripotent stem cells to chondrocytes 
Various growth factors have been tested for their ability to enhance cartilage formation in 
the outgrowth area. TGFβ-superfamily proteins, such as TGFβ and BMP, are commonly 
used to stimulate chondrogenesis from chick embryonic limb mesenchyme (Duprez et al., 
1996; Kulyk et al., 1989). According to Kramer’s group, addition of BMP2 (2-10 ng/ml) or 
BMP4 (10 ng/ml) increases, but TGFβ1 (2 ng/ml) slightly reduces, the number of 
cartilaginous nodules (Kramer et al., 2000). Treatment with BMP2 from day 2 to 5 of 
differentiation (EB formation stage) is sufficient to produce the stimulatory effect. However, 
these observations differ from ours in three respects. 1) We found that the first 5-day 
treatment with 2 ng/ml BMP4 induced mesoderm, including hemogenic angioblasts, in EBs 
(Nakayama et al., 2000; Nakayama et al., 2003). 2) Treatment of the isolated mesoderm with 
BMP4 alone inhibited in vitro chondrogenesis. 3) TGFβ3 (10 ng/ml) and BMP4 (10-50 
ng/ml), or TGFβ3 followed by BMP4, synergistically enhanced chondrogenesis (Nakayama 
et al., 2003). Consistent with our observations, Kawaguchi et al. (2005) have reported that 
exogenous TGFβ3 (10 ng/ml), but not BMP4 (100 ng/ml), added from the stage of 
outgrowth culture, enhances chondrogenesis in the outgrowth, and zur Nieden et al. (2005) 
have demonstrated that addition of BMP2 (10 ng/ml) and TGFβ1 (2 ng/ml) between days 3 
and 5 of differentiation (i.e. EB culture stage) and addition of BMP2 alone during the 
subsequent outgrowth culture results in pronounced up-regulation of cartilage-specific gene 
expression.  
In contrast, Toh et al. (2007) have demonstrated that mesenchymal cells growing out of 
human day 5 EBs generated in the absence of the above-mentioned factors form few, if any, 
cartilage nodules during 21-day outgrowth culture in a serum-containing chondrogenesis 
medium. However, addition of BMP2 (100 ng/ml) during the outgrowth culture enhanced 
cartilage nodule formation (Type II collagen positive) in the outgrowth area, a finding 
similar to that seen for mouse EB outgrowth culture, although sulfated proteoglycan levels 
was not changed significantly.  
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Thus, differences in timing/duration and magnitude of TGFβ and BMP signaling lead to 
different effects of the two factors on chondrogenic differentiation of ES cells. 
3.2 Chondrogenesis from ES cells during 2D-differentiation culture.   
Although the standard differentiation protocol for ES cells involves a 3-dimensional (3D) 
culture leading to EB formation, ES cells can also differentiate as a monolayer during 2-
dimensional (2D) culture. The 2D culture method had not been widely used for the 
generation of mesodermal cell lineages from mouse ES cells, primarily because fewer 
functional cell types are induced and sustained with this method compared with EB 
formation culture, especially in an undefined serum-containing medium. However, the 
advantage of 2D monolayer differentiation is the ease of visualizing and quantitating 
intermediate cell types. Dr. Nishikawa et al. (1998) have elegantly demonstrated that 
differentiation of mouse ES cells on a type IV collagen-coated surface, combined with a 
serial cell sorting using E-cadherin, platelet derived growth factor receptor-α (PDGFRα), 
vascular endothelial growth factor receptor-2 (FLK1/KDR) and vascular endothelial (VE)-
cadherin markers, not only led to the effective generation of hemogenic angioblasts, but also 
allowed the determination of the intermediate cell types in the differentiation pathway 
(Low-density plating, Fig. 1-2). As described below, a similar 2D-differentiation method has 
been applied to human ES cells to generate MSC-like mesenchymal cells (Barberi et al., 2007; 
Nakagawa et al., 2009). 
While there have been no reports describing application of the 2D monolayer differentiation 
protocol directly to the development of chondrocytes from human ES cells, one recent 
publication provided interesting data, though limited, on 2D-micromass culture using 
chondrogenic medium with BMP2 (100 ng/ml) added on day 2-3 of culture for the 
differentiation of human ES cells (Gong et al., 2010) (Fig. 1-3). In contrast to the regular EB 
formation method (using KSR-medium with no added protein factors), the method resulted 
in a cell mass that stained strongly with Alcian blue at 14 days. A noteworthy feature of 
differentiation under the conditions described was its unusual rapidity. The chondrocyte 
marker gene Sox9 is already expressed by the time BMP2 is added on day 3 and induces 
expression of the mesendoderm marker gene Brachyury on day 4. Both transcripts 
disappear by day 7, when aggrecan and Col2a1 transcripts are maximal. Since Sox9 is also 
functionally important for cranial neural crest formation, it was not clear what type of 
chondrocyte was preferentially produced under the culture conditions. 
3.3 Chondrogenesis from ES cells using co-culture methods. 
Chondrogenesis is controlled by multiple environmental cues, including signals provided 
through cell-to-cell interaction (e.g. mesenchymal condensation) and secreted 
morphogenetic factors. Co-culture of ES cells with cells that provide the necessary 
environmental cues offers an alternative for chondrogenic differentiation of ES cells. 2D 
differentiation culture of mouse and human ES cells on a layer of supportive cells has been 
used for the development of lymphohematopoietic cells and endothelial cells (Fig. 1-4-1). 
One of the earliest and most successful examples is the demonstration of pre-B cell genesis 
and two-phase (from primitive to definitive) erythropoiesis from mouse ES cells on the 
op/op mouse bone-derived stromal cell line, OP9 (Nakano et al., 1994, 1996).  Since the mid-
90s, OP9 has become the co-culture partner of choice for developing mesodermal cell types 
from mouse and human PS cells. As for chondrogenesis, Sui et al. (2003) co-cultured drug-
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resistant mouse ES cells with primary limb bud mesenchymes in 2D micromass culture (Fig. 
1-3/1-4-1). After 4 days, the corresponding drug is added to remove progeny from limb bud 
cells and enrich those from the drug-resistant ES cells. Chondrocytes were detected among 
the surviving cells. Limb bud mesenchymes proliferate, condense and differentiate into 
bone and cartilage cells in vivo, and thus are potentially a suitable co-culture partner for 
chondrogenesis. However, as they are isolated from embryos, mesenchymes are not 
appropriate for use in humans. Interestingly, the co-culture partner for chondrogenesis can 
be derived from tissues unrelated to skeleton: e.g. hepatic cells (Lee et al., 2008).   
Probably one of the most successful co-culture methods for directing differentiation of 
human ES cells to chondrocytes is the use of chondrocytes themselves as co-culture partner. 
Primary human (Vats et al., 2006) or bovine (Hwang et al., 2008a) chondrocytes are placed in 
a well insert either directly, or after brief expansion, respectively, and human ES cells are 2D 
cultured underneath for 3-4 weeks in a serum-containing MSC medium in the presence or 
absence of ascorbate, respectively (Fig. 1-5). The resultant human ES cell progeny express 
2.5-3.5 times more type I and type II collagen (the ratio is not changed) and sulfated 
glycosaminoglycan (sGAG) than those generated without chondrocytes, and form a 
cartilage-like area in vivo when transplanted encapsulated in a polymer-based scaffold (Vats 
et al., 2006). Such chondrogenic progeny also grow in the MSC medium, which causes 
dedifferentiation; however, the cells expanded and dedifferentiated for 3 weeks retain 
significant chondrogenic activity when subjected to 3D-pellet culture or hydrogel (arginine-
glycine-aspartate [RDG]-coated polyethyleneglycol [PEG]-based hydrogel, Hwang et al., 
2006b) culture in the presence of TGFβ1 (Hwang et al., 2008a). A 3D coculture of human ES 
cells with irradiated human chondrocytes in a serum-free chondrogenic medium including 
TGFβ1, that resembles the pellet culture for cartilage particle formation, facilitates 
mesenchymal progeny formation from human ES cells. Such mesenchymal cells form 
cartilage particles that stain uniformly with Alcian Blue after expansion in a human serum-
containing medium (Fig. 1-4-2) (Bigdeli et al., 2009). Identification of the critical factors 
produced by the primary chondrocytes may thus provide a route for more efficient 
chondrogenic differentiation of mouse and human PS cells.  
3.4 Cooperation with tissue-engineering technology. 
Simple implantation of mesenchymal cells in combination with a periosteal patch as in ACI, 
necessitates additional surgery to isolate periosteum from the patient, and also fails to 
faithfully reconstitute the architecture of host cartilage within the damaged or diseased area. 
However, conventional cartilage-formation culture results in a small-size cartilaginous 
particle that is structurally disorganized and mechanically weak, and therefore is not 
suitable for clinical-scale cartilage repair. Therefore, attempts have been made to generate 
large engineered cartilage using artificial or bioartificial scaffold with proper 
chondroprogenitor cells. In general, the engineered cartilage is a construct consisting of 
either chondrocytes matured in vitro before implantation, or chondrogenic mesenchymal 
cells, such as expanded chondrocytes and immature chondroprogenitor cells, which are 
expected to (re)differentiate or mature in vivo after implantation. In either case, it is intended 
that the seeded chondroprogenitor cells will survive, grow, differentiate, and reform 
cartilage structure in the scaffold in vitro and in vivo. Many attempts, especially using 
biodegradable polymer scaffolds and hydrogel have been described (reviewed in Jukes et 
al., 2010). Cartilage tissue engineering using MSCs and both types of scaffold has been 
reported (Fukumoto et al., 2003; Richardson et al., 2006). 
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Porous biodegradable polymer scaffolds are based on polylactic acid (PLA), polyglycolic 
acid (PGA), polyvinyl alcohol (PVA) or polyurethanes. Such solid-type scaffolds are rigid 
enough to withstand continuous loading, whereas invasive surgical incision is required for 
implantation. As for application to mouse ES cells, 4 day-old EBs or cells isolated from such 
EBs (formed in a serum-containing medium) were further cultured on a polyethyleneoxide 
terephthalate (PEOT)/polybutylene terephthalate (PBT) scaffold in a serum-free 
chondrogenic medium (Jukes et al., 2008). However, the seeding efficiency of EB cells was 
extremely low and retention of EBs and seeded EB cells within the scaffold during 
chondrogenic differentiation was also poor, leading to inefficient, non-homogeneous 
cartilaginous constructs. In another example, a scaffold made from polycaprolactone (PCL) 
was used. EBs were formed in a serum-containing medium including retinoic acid, then 
outgrowth culture was performed in a serum-containing chondrogenic medium, and the 
outgrowth cells were seeded onto the PCL scaffold (Fecek et al., 2008). Implantation of the 
resulting constructs yielded a poor result, with only a few chondrocyte clusters inside.  
More refined tissue-engineering technology has been used for chondrogenic differentiation 
from human ES cells. The first report demonstrated that polylactic-co-glycolic acid 
(PLGA)/PLA scaffold in combination with Matrigel or fibronectin improved the seeding 
efficiency of human EB-derived cells, leading to cartilaginous area formation in vitro in the 
presence of TGFβ1 (Levenberg et al., 2003). Furthermore, a poly-D,L-lactide (PDLLA) 
scaffold seeded with human ES cells differentiated using the chondrocyte-coculture method 
and implanted in SCID mice, resulted in areas within the scaffold that expressed type II 
collagen at 35 days (Vats et al., 2006), although signs of proteoglycan accumulation were 
weak. 
Hydrogels are water-insoluble but highly absorbent materials, and include a variety of gels 
based on collagen, GAG, agarose, gelatin, alginate, and hyaluronic acid. Hydrogel lacks 
structural integrity but have the major benefits of supporting the homogeneous distribution 
of cells at the desired density within the scaffold, and being associated with the less invasive 
method of transcutaneous injection for implantation. Mouse EB cells encapsulated and 
cultured in natural hydrogels such as agarose and Matrigel,  showed homogenous seeding; 
however the viability of the seeded cells was very poor and the cells did not form cartilage 
(Jukes et al., 2008). In contrast, when EBs were directly encapsulated, cells within the EBs 
had greater viability and chondrogenic differentiation was observed in vitro. Implantation 
into immunodeficient mice, however, resulted in teratoma formation and a failure to detect 
cartilage nodules. As found with synthetic hydrogels, Dr. Elisseeff’s group has reported that 
mouse EBs encapsulated in a PEG-based hydrogel formed cartilaginous tissue structures 
during in vitro culture in the presence of TGFβ1 (Hwang et al., 2006a). As noted above, they 
have further modified the PEG-based hydrogels to promote cell adhesion and spreading by 
the addition of RGD-containing peptides. In the modified gel, MSC-like cells (Hwang et al., 
2008b) and chondrogenically committed cells (Hwang et al., 2008a), derived from human ES 
cells using the EB-outgrowth culture method and the chondrocyte co-culture method, 
respectively, survived and gave rise to many chondrocytes in vitro. Furthermore, when the 
MSC-like cells were pre-treated with chondrocyte-conditioned medium, implantation of the 
PEG-hydrogel construct resulted in cartilage-like tissue formation in damaged articular 
cartilage by 8 weeks (Hwang et al., 2008b). 
In summary, polymer scaffolds and hydrogels work to some extent but are not ideal for 
promoting generation of cartilage from ES cell-derived mesenchymal cells in vitro or in vivo. 
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Although expansion in a chondrocyte-conditioned medium improves the chondrogenicity 
of the mesenchymal cells, there is considerable scope for improvements to scaffolds to 
enhance chondrogenesis. In this sense, novel biomaterials, such as hybrid gel/scaffolds 
(Richardson et al., 2008), nanofibrous scaffold (Hu et al., 2009; Li et al., 2005) and bioartificial 
matrixes are of great interest.  
3.5 Chondrogenesis enhancement by gene modification 
Directed differentiation of ES cells can be controlled by intracellular proteins such as cell-
type specific transcription factors. Controlled expression of key differentiation regulators via 
gene transfer is therefore an alternative strategy for the achievement of lineage-specific 
differentiation of PS cells: e.g. hepatocytes (Ishizaka et al., 2002) and skeletal muscles 
(Darabi et al., 2008). The most likely gene candidates for directing chondrogenesis are the 
high-mobility group (HMG) box protein Sox9 and paired-box-gene Pax1 (Bi et al., 1999; 
Wallin et al., 1994). Constitutive overexpression of Sox9 or transfection of Sox9, in 
combination with Sox5 and Sox6, can induce the expression of cartilage marker genes in the 
absence of specific growth factors or culture conditions (Ikeda et al., 2004; Kim et al., 2005). 
However, such gene transfer-based facilitation of chondrogenesis is unlikely to be of use in 
the clinical setting. 
4. Identification of chondroprogenitor cells derived from pluripotent stem 
cells: undefined mesenchymal cells and MSC-like cells 
Homogenous populations of chondroprogenitor cells are unlikely to be obtained from PS 
cells solely by directed differentiation culture. However, either for cell transplantation or for 
engineered cartilage formation before transplantation, purified chondroprogenitor cells are 
needed, especially because the least contamination with teratoma-forming, undifferentiated 
ES cells will be harmful. Therefore, a convenient yet effective method for purifying the 
chondroprogenitors is required. Surface molecules specifically expressed on 
chondroprogenitor cells have been used to isolate them by fluorescence-activated cell 
sorting (FACS). We published the first attempt to induce, identify, purify and characterize 
chondroprogenitors from differentiating mouse ES cells (Nakayama et al., 2003). In 
particular, the research described focused on 1) the genesis/induction of FLK1-PDGFRα+ 
progeny, which showed a transcriptional profile of lateral plate/extraembryonic mesoderm 
and posterior paraxial mesoderm, and the FLK1+PDGFRα- progeny, which showed 
lymphohemogenic activity, and the corresponding transcriptome in a serum-free medium, 
and 2) the control of chondrogenic activity in these fractions of progeny. We demonstrated 
using 2D and 3D chondrogenesis assays that both mesenchymal progeny have full 
chondrogenic activity: from mesenchymal condensation to hypertrophic chondrocyte 
formation. Similarly, Sakurai et al. (2006) demonstrated, as part of their attempt to 
characterize what they claim to be primitive mesoderm/mesendoderm (FLK1+PDGFRα+ 
progeny), paraxial mesoderm (FLK1-PDGFRα+ progeny) and lateral plate mesoderm 
(FLK1+PDGFRα- progeny), generated simultaneously from mouse ES cells using 
Nishikawa’s 2D-differentiation method in a serum-containing medium, that the primitive 
mesoderm and paraxial mesoderm were able to form cartilage nodules during 2D 
micromass culture. Chondroprogenitor cells from human ES cells have not yet been purified 
and characterized to the extent of those derived from murine ES cells. 
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4.1 Undefined mesenchymal cells from EBs and EB-outgrowth.  
Chondrogenic activity in human ES cell-derived progeny was first reported by Levenberg et 
al. (2003) from a study to demonstrate the effect of a 3D polymer scaffold on differentiation 
of human ES cell progeny. The progeny were EB cells prepared from 8 to 9-day-old EBs 
formed in KSR-based serum-free medium in the absence of exogenously added protein 
factors, and used directly without expansion or purification. Toh et al. (2007) have also 
demonstrated that uncultured, unfractionated EB cells isolated from human day 5 EBs 
formed in the absence of exogenous protein factors give rise to type II collagen-positive 
cartilage nodules when subjected to 2D-micromass culture in a serum-containing medium. 
The effect of BMP2 (100 ng/ml) added during micromass culture was, however, minimal. 
Dr. Athanasiou and his colleagues have published a series of reports on chondrogenesis 
from human ES cells using an EB cell-re-aggregation method (Hoben et al., 2008; Koay et al., 
2007; Koay & Athanasiou, 2008, 2009). ES cells are differentiated as a form of EB for 3 weeks 
in various media based on a 0-20% serum-containing chondrogenic medium with or without 
the addition of combinations of growth factors such as TGFβ, PDGF, IGF, sonic hedgehog 
and/or BMP2/4/6. EBs are then disrupted, and the cells are resuspended without 
expansion or purification at a high density in a small volume (e.g. 20 μl) of 0-1% serum-
containing chondrogenic medium with or without TGFβ1 or IGF1, and transferred into a 3 
mm, 2% agarose well. Although a macroscopic particle forms in 4 weeks, there is only a 
weak indication that cartilage particles form, as assessed by the production of ECM rich in 
type II collagen and GAG. Interestingly, TGFβ+BMP2/4 treatment during EB culture in the 
serum-containing chondrogenic medium is most effective at stimulating the accumulation of 
GAG and type VI collagen in 3 weeks, whereas EB culture in an agarose-coated Transwell, 
conditions under which chondrocytes are co-cultured as a monolayer, strongly stimulates 
the accumulation of type II collagen within EBs (Hoben et al., 2009). In summary, crude EB 
cells without expansion or sub-fractionation failed to show robust chondrogenic activity in 
any of the in vitro culture methods used. The addition of protein factors at various steps of 
differentiation had no dramatic effect. 
Attempts have also been made to generate morphologically uniform mesenchymal progeny 
from crude EB cells, before assaying chondrogenesis. Human ES cells are differentiated in 
the form of EB for 4 to 10 days in the absence of exogenous protein factors in a serum-
containing medium (Toh et al., 2009; Xu et al., 2004), or the standard KSR-based serum-free 
medium (Hwang et al., 2006b; Hwang et al., 2008b; Terraciano et al., 2007). The resultant EBs 
are either attached to a plate and cultured in the corresponding factor-free EB medium to 
allow the outgrowth of mesenchymal cells (Fig. 1-1), or subjected to 2D micromass culture, 
from which mesenchymal cells are isolated (Toh et al., 2009). Multiple passaging of the 
outgrowth cells in the serum-containing MSC medium results in a morphologically 
homogeneous mesenchymal cell population (Fig. 1-6). However, such cells are not 
chondrogenic in standard 3D pellet culture in the presence of TGFβ. Weak chondrogenic 
activity was detected only when the cells were encapsulated in a special scaffold (e.g. RDG-
PEG hydrogel) and stimulated by periodic pressures (Terraciano et al., 2007). Interestingly, 
expansion of the mesenchymal cells from 2D micromass culture in the presence of growth 
factors to some extent preserved the ability of the cells to accumulate Alcian blue-positive 
matrix in the following 3D pellet assay (Toh et al., 2009). The significant level of type I 
collagen in the resulting particles suggested the formation of fibrocartilage.   
As described above, chondrocyte-coculture during EB formation improved the “expansion” 
strategy for obtaining morphologically uniform chondroprogenitors. For example, human 
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ES cell differentiation with irradiated chondrocytes using the 3D pellet culture-like method 
in a serum-free chondrogenic medium with TGFβ1 resulted at day 14 in a mixture of cells 
that included chondrocytes. Although the chondrocytes bore similarities to co-cultured 
irradiated chondrocytes, their expansion in a human serum-containing medium led to the 
accumulation of mesenchymal cells with the capacity to reform a cartilage pellet that stained 
uniformly with Alcian Blue (Bigdeli et al., 2009). While such cells were not adipogenic and 
only weakly osteogenic, the chondrocyte co-culture method is suitable for specifying 
chondroprogenitor cells from human ES cells.   
4.2 ES cell-derived MSC-like cells.  
MSCs are in vitro-defined chondroprogenitor cells present in various adult tissues. 
Therefore, ES cell-derived chondroprogenitor cells may possess MSC-like properties. The 
first demonstration of the genesis of MSC-like cells from human ES cells was that of Barberi 
et al. (2005), who used a 2D co-culture method for differentiation. A long-term (40 day) 
human ES cell differentiation on the OP9 stromal cell line in a serum-containing medium 
was followed by CD73+ cell isolation and further culture in a serum-containing MSC 
medium without OP9. The method was later modified to include a stroma-free 2D 
differentiation culture, in which human ES cells are cultured at low cell density on a gelatin-
coated plate in serum-free medium without protein factors for 20 days (Barberi et al., 2007) 
to produces mesenchymal cells. CD73+ cells emerged at 14 days of expansion of the 
mesenchymal cells in serum-containing MSC medium. The CD73+ cells, sorted then 
maintained in the same medium, showed bone-cartilage-fat “tri-lineage” potential. 
Nakagawa et al. (2009) used a similar method to produce mesenchymal cells with in vitro tri-
lineage potential. They plated human ES cells directly onto gelatin-coated plates and 
maintained them in serum-containing medium in the presence of FGF2. Interestingly, 
however, unlike other studies, TGFβ did not stimulate the accumulation of GAG and type II 
collagen during 3D-pellet chondrogenesis culture.  
The expanded EB-outgrowth cells in serum-containing MSC medium were osteogenic and 
adipogenic, but poorly chondrogenic (Hwang et al., 2008b), and lacked the expression of the 
MSC marker CD73 (Hwang et al., 2006b). Interestingly, expansion of the outgrowth cells in a 
chondrocyte-conditioned medium significantly increased the chondrogenic ability of the 
cells and was associated with a better outcome after transplantation of the cells into a critical 
size cartilage defect in the femoropatellar groove of nude rats. Probably the most extensive 
analysis of MSC-genesis through EB-outgrowth cells was the report by Mahmood et al. 
(2010), which describes the differentiation of human ES cells in the absence of exogenous 
protein factors, but the presence of a high concentration (10 μM) of the small molecule 
inhibitor of Nodal/Activin/TGFβ receptor (ALK7/4/5) kinase, SB431542, for 10 days in a 
KSR-based serum-free medium. Although SB431542 is inhibitory for mesoderm 
specification, even at a lower concentration (Gadue et al., 2006), and induces neuronal 
differentiation (Smith et al., 2008) from mouse and human ES cells, transcripts representing 
myogenic cells (as well as neural cells) were induced at day 10. EB-outgrowth culture and 
subsequent maintenance culture for the mesenchymal cells was performed in a chemically 
defined serum-free medium in the presence of 1 μM SB431542. Cells expressing myocytic 
and neuronal proteins persisted after cell expansion. To generate CD73+ MSCs, such cell 
populations must be cultured in a serum-containing medium for 20 days, during which 
signs of myocytes and neuronal cells disappear. The chondrogenic activity of the MSC-like 
cells developed by this method was demonstrated in vivo by studies in nude mice.   
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Overall, the chondrogenic activity of the human ES cell progeny reported thus far is weak, 
and not highly susceptible to enhancement by the protein factors tested. Interestingly, for 
the genesis of MSC, expansion culture of the progeny in a serum-containing MSC medium 
appears to be essential. Therefore, the chondrogenic activity as part of the MSC activity can 
be generated/enhanced during such culture. However, expansion culture of human ES cell 
progeny does not always accumulate MSC-like chondroprogenitor cells, possibly reflecting 
the low yield of MSCs within the progeny population. It is worth noting that, again, 
chondrocyte-coculture, either during EB formation or during the expansion culture phase, 
improved the chondrogenic activity of the human ES cell progeny, even after expansion.   
5. Lineage–specific chondroprogenitors from pluripotent stem cells 
 
Fig. 2. Key developmental intermediates from pluripotent stem cells to chondrocytes 
Embryonic chondrocytes are responsible for the robust chondrogenesis that occurs during 
embryogenesis. The three sources of embryonic chondrocytes and their precursor cells 
(chondrogenic mesenchymes and chondroprogenitors) are lateral plate mesoderm for limb 
joint and growth plate chondrocytes, paraxial mesoderm for vertebral and rib chondrocytes, 
and cranial neural crest for craniofacial chondrocytes (Fig. 2). The mesodermal chondrocytes 
give rise to hyaline cartilage at joint surfaces and fibrocartilage in the patella, meniscus, and 
vertebral disk. In contrast, cranial neural crest-derived chondrocytes make craniofacial 
cartilage that is mostly fibrocartilage or elastic cartilage. Therefore, embryonic chondrocytes 
from lateral plate mesoderm, paraxial mesoderm or cranial neural crest might preferentially 
generate different types of cartilage in a given environment. Recent observations that bone 
marrow MSCs arise from the neural crest in young mice (Morikawa et al., 2009; Takashima 
et al., 2007) suggest that the chondrogenic potential of adult MSCs and mesodermal 
chondroprogenitor cells might also be different. 
In vitro differentiation of mouse and human ES/iPS cells is thought to represent the early 
stages of embryogenesis. In fact, progeny displaying characteristics of a particular germ-
layer can be induced in an exogenous protein factor-dependent manner from mouse ES 
(reviewed in Gadue et al., 2005; Keller, 2005; Nishikawa et al., 2007). The factors used are 
developmental factors, defined by genetic and embryological studies, which provide 
essential signaling between pluripotent cells (inner cell mass and epiblast) and the 
differentiated cell type of interest. However, to date, only a small number of reports describe 
such a “factor biology” approach to the generation of chondrocytes with distinct germ-layer 
specificity (Kawaguchi et al., 2005; Nakayama et al., 2003; Sakurai et al., 2006; Tanaka et al., 
2009), and these have all dealt with mouse ES cells. There have been no reports of controlled 
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differentiation of human ES/iPS cells to lineage-specific chondrogenic progeny. A few 
reports have addressed the effects of TGFβ1, BMP2, and Activin (or its inhibitor SB431542) 
on human ES cell differentiation. Although the origin of the developed chondroprogenitors 
has not been explored, the expression of mesodermal genes in the progenitor population 
after extensive expansion has been reported (Harkness et al., 2009).  
6. Mesodermal chondroprogenitors: differential specification and prospective 
isolation from differentiating pluripotent stem cells 
Applying the “factor biology” strategy, progeny displaying characteristics of different types of 
mesoderm are induced from mouse ES cells in a defined medium (Gadue et al., 2006; Nostro et 
al., 2008; Tanaka et al., 2009). A similar principle has been applied to human ES/iPS cells to 
develop various mesodermal cell types (reviewed in Murry & Keller, 2008; Nishikawa et al., 
2008). Mesoderm is developed through gastrulation in vivo, a time when posterior primitive 
ectoderm (or epiblast) undergoes epithelial-to-mesenchymal transition to give rise to 
extraembryonic mesoderm, cardiac and lateral plate mesoderm, and subsequently to paraxial 
mesoderm and axial mesendoderm. The TGFβ-superfamily (TGFβ, Nodal/Activin, and BMP), 
Wnt, and FGF are involved in these processes, and are effective in different doses and 
combinations in determining the differential specification of mesodermal cells from ES cells 
(reviewed in Gadue et al., 2005; Keller, 2005; Nishikawa et al., 2007). For transplantation in the 
clinic, it will be necessary to purify the generated mesodermal chondroprogenitor cells from 
unwanted contaminants. FLK1/KDR and PDGFRα are useful surface markers with which to 
monitor the early stages of mesoderm development in the mouse. Flk1 expression is detected 
in extraembryonic and lateral plate mesoderm (Yamaguchi et al., 1993), which gives rise to 
somatopleuric mesoderm, the origin of limb bud chondrogenic mesenchymal cells. In contrast, 
Pdgfra expression is detected in most early mesodermal cells, but surface expression of 
PDGFRα is restricted in paraxial mesoderm derivatives (Takakura et al., 1997). Dr. Nishikawa 
and his colleagues (1998) have started using these markers for the identification and isolation 
by FACS of mesodermal progeny from mouse ES cells. Our group has combined factor 
biology and FACS purification to selectively generate, isolate and characterize 
chondroprogenitors derived from mouse and human PS cells.    
6.1 Signaling code for differential specification of ES cell progeny. 
In applying the combined factor biology/FACS purification approach, mouse ES cells are 
differentiated in a serum-free medium and the resulting EBs are harvested at an appropriate 
time. Single-cell preparations from EBs are immunostained for FACS using antibodies to E-
cadherin (E), N-cadherin (N), PDGFRα (P), and FLK1 (F). The E- EB cells, free of 
undifferentiated ES cells and endoderm, are further fractionated with N, F and P, and 
subjected to bioassays and in vivo assays. Brachyury(T)+ mesendodermal/early mesodermal 
progeny are generated in 3 days in the presence of exogenous WNT3a and endogenous 
Nodal-like activity. Although exogenous BMP4 induces T, it does so through induction of 
endogenous WNT and Nodal-like activities (Tanaka et al., 2009). The P+ progeny, the first 
sign of mesenchymal cell genesis, become obvious by day 4. When Activin A is provided 
exogenously with WNT3a or BMP4, F+ cells start to accumulate, as was also reported by the 
Keller group (Fehling et al., 2003). Approximately 90% of the F+ and/or P+ EB cells 
developed by day 5 are derived from T+ progeny and are also N+, implying that the cells 
include mesodermal derivatives (Fig. 3).  
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Fig. 3. Chondrogenic paraxial mesoderm from mouse pluripotent stem cells 
Global transcriptional profiling has shown that the expression of genes associated with 
pluripotent stem cells (Oct3/4/Pou5f1 and Nanog) and epiblasts (Fgf5) is confined to the T-
N-F-P- fraction (which is mostly E+). Markers for rostral paraxial mesoderm such as 
Tcf15/Paraxis, Uncx, Meox1, Tbx18 and Mesp2, are confined to the T+N+F-P+ cells generated 
when WNT signaling is activated and BMP signaling is inactivated. In contrast, Foxf1 and 
Hand2, expressed in lateral plate and extraembryonic mesoderm, are detected mostly in the 
same T+N+F-P+ cell fraction, but generated only under active WNT and BMP signaling. The 
genes associated with hemogenic mesoderm/endothelium, such as Scl/Tal1, Hhex, Ikaros, 
Chd5, Tie2/Tek and Cd34, are exclusively expressed in the T+N+F+P- fraction generated 
efficiently when WNT, BMP and Nodal/Activin signaling are activated via exogenous 
factors (Tanaka et al., 2009).  
Consistent with the notion that BMP signaling is inhibitory to ES cell-derived neurogenesis, 
and that head induction depends on both BMP/Nodal-inhibition and WNT inhibition in 
vivo, T-N+F-P- neural precursors, expressing early neural markers such as Sox1, Nestin, Pax6, 
Neurod and Neurog, are differentiated from ES cells when none of the three signaling 
mechanisms is activated (Fig. 5). Interestingly though, when BMP signaling was activated in 
the presence of WNT inhibitors, non-mesodermal T-NdimF-P+ mesenchymal cells were 
generated at low levels, as discussed in detail below.  
Lateral plate/extraembryonic mesoderm specification from mouse ES cells, as judged by 
gene expression profiling, is achieved by exogenous BMP4 or WNT3a, although both WNT 
and BMP signaling are activated under either condition. In contrast, rostral paraxial 
mesoderm specification requires BMP inhibition when an optimized level of WNT3a is 
provided. These results imply that activation of either BMP or WNT signaling results in the 
activation of the other during ES cell differentiation. In support of this idea, exogenous 
BMP4 upregulated the levels of Wnt mRNAs (Wnt5a, Wnt4 and, weakly, Wnt2, Wnt5b and 
Wnt11) and suppressed the level of the Wnt inhibitor gene (Sfrp1 and Sfrp2) mRNAs. On 
the other hand, exogenous WNT3a elevated expression of Bmp and Nodal transcripts.  
6.2 Prospective isolation of mesodermal chondroprogenitors from mouse ES cells. 
We were the first to report the use of the cell surface markers FLK1 (F) and PDGFRα (P) to 
enrich by FACS a population of mesenchymal progeny that demonstrated chondrogenic 
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activity in vitro from a crude mixture of differentiated ES cells (Nakayama et al., 2003). The 
conditions for ES cells differentiation produced lateral plate mesoderm and extraembryonic 
mesoderm, but no rostral paraxial mesoderm (WNT3a[or BMP4]±Activin A, Fig. 3). The 
isolated F-P+ progeny contained lateral plate/extraembryonic mesoderm and posterior 
paraxial mesoderm. The F+P- progeny contained hemoangiogenic (lateral 
plate/extraembryonic) mesoderm. Both cell fractions reproducibly showed chondrogenic 
activity in vitro. Rostral paraxial mesoderm transforms itself into somite, an epithelial 
structure that later gives rise to progenitors for skeletomyogenesis and axial skeletogenesis. 
We have also recently reported that under conditions in which no lateral 
plate/extraembryonic mesoderm is specified but rostral paraxial mesoderm is selectively 
induced from ES cells (WNT3a+Noggin, Fig. 3), the F-P+ progeny represents the rostral 
paraxial mesoderm and is also rich in chondroprogenitors (Tanaka et al., 2009). 
Unfortunately, F-P+ is not a characteristic of either type of chondrogenic mesoderm. The 
availability of a reporter cell line using a mesoderm type-specific transcription factor gene 
(e.g. Meox1) would be a useful tool for studying the cellular developmental pathway and 
further purification.  However, considering future clinical application, cell surface markers 
specific for each mesoderm-type and the chondroprogenitors will be needed. 
6.3 Prospective isolation of mesodermal chondroprogenitors from human ES cells. 
The prospective isolation of lineage-specific chondroprogenitor cells from human PS cells 
using specific cell surface markers without extensive expansion has not been reported. 
However, an interesting report published recently describes how the delta-like 1/fetal antigen 
1 (dlk1/FA1), a transmembrane protein belonging to the Notch/Delta/Serrate family, is useful 
in some cases (Harkness et al., 2009). We reported a serum-free differentiation method for 
human ES and iPS cells that favors the generation of hematopoietic progenitor cells in an 
exogenous WNT3a-dependent manner (Wang & Nakayama, 2009; Wang et al., 2010) (Fig. 4, 
right panel), which we have now adapted to promote paraxial mesoderm formation. 
Specification of paraxial mesoderm from human ES and iPS cells was achieved using 
conditions similar to those described for mouse ES cells. In addition, FACS-purified human 
paraxial mesoderm was found to have chondrogenic activity when measured by the 
conventional 2D micromass and 3D pellet chondrogenesis assays (under the same condition  
 
 
Fig. 4. Chondrogenic paraxial mesoderm from human pluripotent stem cells  
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established for the mouse ES cell-derived rostral paraxial mesoderm) (Umeda, et al. 
unpublished observations; Fig. 4, left panel).  Chondrogenic activity of the isolated paraxial 
mesoderm is robust, so that RDG-hydrogel or another scaffold is not necessary for in vitro 
assays. 
7. Directed specification of MSC-like chondroprogenitors from pluripotent 
stem cells: neural or potentially other non-mesodermal lineages 
Cranial neural crest cells arise from the forebrain (to form the frontonasal skeleton), the 
midbrain (to form the facial bone and cartilage and jaw bone) and the hindbrain (to form the 
middle ear and neck bones), in distinct populations. They differ from trunk neural crest in 
their potential to differentiate into cartilage, bone and connective tissues even in vitro 
(Abzhanov et al., 2003). Cranial neural crest cells are mesenchymal cells, generated from the 
neuroepithelium/surface ectoderm border of the fore-, mid- and hindbrain via epithelial-to-
mesenchymal transition. They migrate anteriorly or ventrally to colonize distinct regions 
(the frontonasal process or pharyngeal arch 1 to 3) and form region-specific skeletal 
elements. Wnt, BMP, FGF, and Notch pathways are involved in neural crest cell 
specification, although the timing and order of the signals required is not fully understood 
(Steventon et al., 2005).    
7.1 MSC-like cells from mouse ES cell: non-mesodermal origin. 
Neural crest derivatives such as peripheral nerve cells were first generated from mouse ES 
cells using undefined stromal cell-derived activity (which is thought to contain Nodal-
inhibitor and WNT-inhibitor) to induce neural commitment, followed by BMP4 treatment 
(Mizuseki et al., 2003). In contrast, while a brief treatment with retinoic acid during EB 
culture in a serum-containing medium failed to induce T, MSC-like tri-lineage potential cells 
developed during the subsequent EB-outgrowth culture. A sign of neural crest cell 
formation was also detected (Kawaguchi et al., 2005), consistent with the finding from 
 
 
Fig. 5. Non-mesodermal chondroprogenitor from mouse pluripotent stem cells 
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lineage-tracing analysis that MSCs arise from the neural crest during mouse embryonic 
development (Morikawa et al., 2009; Takashima et al., 2007). We have also produced non-
mesodermal (as judged by the lack of T expression) mesenchymal cells, i.e. T-NdimF-P+ cells 
(hereafter called T-P+ cells) from the isolated T-N+F-P- neural progeny (hereafter called T-P- 
cells) that are generated from mouse ES cells without retinoic acid or any particular protein 
factors (Fig. 5, Un-induced). When the isolated T-P- cells were subjected to neurosphere 
culture in the neural crest stem cell culture medium (Wong et al., 2006), T-P+ cells emerged 
in 4 days. MSC-like spindle-shaped mesenchymal cells, which are strongly chondrogenic in 
2D micromass culture (data not shown), can be generated from such T-P+ cells after brief 
expansion in serum-containing MSC medium. These mesenchymal cells are probably of 
neural origin but their relevance to neural crest has not been established. 
Direct differentiation of mouse ES cells to similar non-mesodermal T-P+ mesenchymal cells 
has also been achieved by the addition of BMP4 or WNT3a from day 0 of differentiation in a 
serum-free medium (Fig. 5, Induced). The T-P+ cell population appearing from day 4 of 
differentiation is enriched in chondrogenic activity that is detectable from day 6. In addition, 
CFU-F activity also emerges from day 6, and is confined in the T-P+ fraction. The 
mesenchymal/fibroblastic cells derived from the resulting colonies spontaneously gave rise 
to Oil Red O+ adipocytes on reaching confluence (data not shown). Mineral deposition was 
readily detected within 20 days of culture in osteogenic medium (data not shown). Thus, the 
chondrogenic T-P+ progeny possess adult MSC-like (tri-lineage potential plus CFU-F) 
activity, although the lineage relationship of this population of cells with neural crest has 
not been demonstrated.   
7.2 Non-mesodermal MSC-like cells from human ES cells. 
Mesenchymal cells with MSC-like phenotypes can also be isolated during directed neural 
crest cell differentiation from human PS cells (Lee et al., 2007; Mahmood et al., 2010; Zhou & 
Snead, 2008). Although a morphologically homogenous cell population can be obtained 
simply by subsequent passaging (Bigdeli et al., 2009; Hwang et al., 2006b; Mahmood et al., 
2010), purification of particular mesenchymal cells by mechanical dissection based on 
morphological criteria (Hwang et al., 2008a) or by FACS using MSC-specific cell surface 
markers (Barberi et al., 2005; Lee et al., 2007) helps to enrich functional MSC-like cells and 
demonstrate their multi-lineage differentiation into fat, cartilage, bone, and muscle cells. The 
development of MSCs often requires long-term culture (sometimes for more than 2 months) 
in a serum-containing medium. A challenge for the future will be to determine how 
extensive expansion culture is associated with the genesis of MSCs from ES cell progeny. 
8. Optimization of the factor environment for chondrogenesis from PS cell-
derived chondroprogenitor cells 
The 2D micromass or 3D pellet cultures, in which cells are maintained at a very high 
density, can mimic precartilage condensation as observed during the early stage of 
chondrogenesis. Both culture systems have been extensively used to differentiate embryonic 
limb mesenchymal cells into chondrocytes, and to induce chondrogenic differentiation of 
mesenchymal cell lines (Denker et al., 1995) and MSCs (Johnstone et al., 1998; Mackay et al., 
1998; Yoo et al., 1998). Therefore, these assays have been used for verifying chondrogenic 
activity of the ES cell progeny. Cartilaginous particles formed by the 3D pellet culture allow 
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histological and immunohistochemical analyses, which in turn provide semi-quantitative 
information on the type of cartilage formed. Chondrogenesis does not occur spontaneously, 
particularly in a serum-free environment, but must be stimulated by the addition of protein 
factors. According to the reports, factors thus far tested for crude, expanded or purified ES 
cell progeny are largely resemble those used for chondrogenic induction from human MSCs, 
namely TGFβ, BMP2/4, BMP6/7. However, many other signalling molecules are known to 
be essential for chondrogenesis (Fig. 6A). There is a possibility that such non-TGFβ-BMP 
signaling mechanisms may functionally distinguish the chondroprogenitor cells of different 
origin, which would support the hypothesis that the different lineage-specific 
chondroprogenitor cells would behave differently in a given environment in vivo. 
 
 
Fig. 6. Growth factor signaling requirement for mesodermal chondrogenesis in vivo and in 
vitro 
To demonstrate that the mesodermal progeny generated from mouse ES cells are capable of 
forming a macroscopic cartilage particle dependent on added protein factors, we employed 
the 3D pellet assay method based on a chemically-defined serum-free medium, originally 
established for adult MSCs (Johnstone et al., 1998; Mackay et al., 1998; Yoo et al., 1998), and 
developed a 2D micromass culture method using the same serum-free medium (Nakayama 
et al., 2003). Combined with the serum-free EB formation method (Johansson & Wiles, 1995; 
Nakayama et al., 2000; Wiles & Johansson, 1997), we have established an entirely serum-free 
culture system that supports differentiation from ES cells to mesodermal progeny, and on to 
mesodermal chondrocytes (Nakayama et al., 2003; Tanaka et al., 2009). The resulting ES cell-
derived mesodermal progeny has proven sensitive to environmental cues such as PDGF, 
TGFβ and BMP4 in the serum-free pellet culture and responds to them by producing 
different types of cartilage particle: e.g. proteoglycan-rich, type I collagen-poor hyaline-like 
cartilage, or proteoglycan-poor, type I collagen-containing fibrocartilage (Nakayama et al., 
2003). TGFβ alone facilitates stable particle formation but cartilage matrix deposition is 
weak, whereas TGFβ+PDGF allows uniform deposition of cartilage matrix in the particle 
(Fig. 6B). TGFβ+epidermal growth factor (EGF) forms a large particle consisting mainly of 
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undifferentiated mesenchymal cells that do not deposit cartilage matrix. TGFβ+FGF results 
in a large particle comprising a thick perichondrial cell layer on the surface and 
hypertrophic-like chondrocytes inside, which is associated with weak deposition of cartilage 
matrix.   
9. Future perspective 
Since first reported by Kremer, et al. in 2000, research on chondrogenesis from PS cells has 
made rapid progress. The question of whether ES cell-derived chondroprogenitor cells are 
MSCs has been addressed primarily with human ES cells. A consistent observation in all 
reported methods is that the genesis of MSCs from ES cells requires expansion of precursor 
(mesenchymal) cells for various times in a serum-containing MSC medium. What is the 
critical role of serum in the process? Furthermore, another interesting question relates to the 
identity of chondrocyte-derived secreted signals that best support the genesis and 
maintenance of the chondroprogenitor and MSC activities from human ES cells. Defining 
both signaling components and mechanisms will shed light on the fundamental biological 
mechanism of the genesis of MSC activity in vivo. On the other hand, lineage origin of the 
developed chondrocytes or their precursor (mesenchymal) cells has never been addressed. 
There are, however, good reasons to hypothesize that the ES/iPS cell-derived embryonic 
chondrocytes differ from adult MSCs in their ability to regenerate hyaline cartilage, and 
ES/iPS cell-derived embryonic chondrocytes also differ, depending on their lineage origin, 
in their efficiency and preference for forming particular types of cartilage. To address these 
suggestions, greater control of the differentiation of PS cells is needed to allow production of 
sufficient lineage-specific chondroprogenitors for comparative preclinical (or clinical) 
studies with adult MSCs. For example, methods need to be established for facilitating 
maturation of rostral paraxial mesoderm to Pax1-positive sclerotome, producing Prrx1-
expressing limb mesenchyme from lateral plate mesoderm, and improving differentiation 
and isolation methods for cranial neural crest and their osteochondrogenic progeny from 
human PS cells. In addition, finding the critical environmental cue or cues that direct the 
type of cartilage formed from human PS cell-derived chondrocytes of a particular 
developmental origin will help to generate that type of cartilage in vitro (in scaffold) and in 
vivo.  Such investigations will facilitate the establishment of a new cell-based therapy for the 
treatment of cartilage defects. In this context, it is worth noting that a human ES cell-derived 
fibrocartilagenous particle transplanted to a size-matched osteochondral defect in rat knee 
showed multi-step changes in the matrix and type of component cells (Toh et al., 2010).  In 
addition during preparation of this review, one new paper reporting that mesodermal 
differentiation of human ES cells in a 2D culture using altered growth factor treatments in a 
chemically defined medium: i.e. WNT3a and Activin A, then BMP4 and FGF2, and then 
BMP4 is replaced gradually with GDF5, which resulted in Sox9 and type II collagen 
expressing chondrocytes, was published (Oldershaw et al., 2010).    
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